Pharmaceutical company WuXi AppTec’s former Mendota Heights location is expected to close and 124 of its employees to be laid ...

WuXi AppTec, the Shanghai-based biotech giant, has sold its South Philly-based WuXi Advanced Therapies contract manufacturing unit to New York-based Altaris LLC, easing worries that federal limits ...

[5] If the sum of the data below is inconsistent with the total, it is caused by rounding [6] If the sum of the data below is inconsistent with the total, it is caused by rounding ...

WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on 18 March 2025.

In response to the news that the US will soon announce significant import tariffs on pharmaceuticals, Edward Hu, Vice ...

Medical device testing and consulting firm NAMSA is laying off dozens of employees after it acquired WuXi AppTec’s medtech testing division in St. Paul earlier this year. Christopher Rupp, NAMSA’s ...

WUXI APPTEC (02359.HK) announced the plan of repurchase of the company's A-shares through bidding for the second time in 2025 ...

With the fate of the BIOSECURE Act currently in limbo, WuXi AppTec is looking on the brighter side for 2025. Still, geopolitical uncertainties under the second Trump administration loom large over ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

SHANGHAI, March 31, 2025 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life sciences ...

Our forward-looking statements do not constitute any profit forecast by our management nor a undertaking by WuXi AppTec Co., Ltd. ("WuXi AppTec" or the "Company") to our investors. ACCORDINGLY ...